Resorptive intramedullary implant between two bones or two bone fragments

Information

  • Patent Grant
  • 12059186
  • Patent Number
    12,059,186
  • Date Filed
    Tuesday, July 9, 2019
    5 years ago
  • Date Issued
    Tuesday, August 13, 2024
    3 months ago
Abstract
The invention relates to a resorptive intramedullary implant between two bones or two bone fragments. The implant includes a single-piece body (1) having a generally elongate shape and having, at each end, areas for anchoring to the bone portions in question, characterized in that one of said areas (A1) has a cylindrical cross-section while the other area (A2) has a flat cross-section.
Description
FIELD OF THE INVENTION

The invention relates to the technical field of orthopedic implants, particularly for arthrodesis and osteosynthesis.


More particularly, the invention relates to an intramedullary implant for arthrodesis between two bone parts or osteosynthesis between two bone fragments, particularly in the case of the hand or foot.


BACKGROUND OF THE INVENTION

Different solutions have been proposed to achieve these functions.


For example, a solution comes from the teaching of patent application FR 2,884,406 [US 2008/0177262], of which the applicant of the present application is also the applicant. This patent describes an intramedullary osteosynthesis device constituted of an elongated body whose ends constitute anchor zones cooperating with the bone parts to be immobilized. The anchor zones are shaped and made of a material selected to enable insertion into the bone parts, then to ensure an anchor in the bone parts by preventing any rotational movement by resisting traction and by maintaining a compression force.


Another solution also comes from patent application FR 07.02003 [US 2010/0131014], also from the same applicant. This document describes an implant in the form of two anchor zones connected by a central zone and whose general shape is substantially inscribed in a very elongated rectangle of X-shape, so as to form in the anchor zones two legs adapted to move apart by elastic or shape-memory effect.


From this design, different criteria have been established to make the implant easy to place and efficient in order to create a primary and secondary stability for the osteosynthesis or arthrodesis site.


However, these solutions are not adapted for the case of an implant made of resorptive material.


BRIEF SUMMARY OF THE INVENTION

From this state of the art, the object that the invention proposes to attain is further improving the anchor and the stability of the implant as well as its adaptation to the morphology of the implantation site when the implant is made of resorptive material.


To solve such a problem, a resorptive intramedullary implant between two bones or two bone fragments has been designed and developed; it is constituted, in a known manner, of a single-piece body having a general elongated shape with, at each end, zones for anchoring to the bone parts being considered. According to the invention, one of the zones has a cylindrical shape, whereas the other zone is flat.


Advantageously, the implant is made of a resorptive material whose mechanical properties are determined to last the time necessary for the consolidation, so that the implant is resorbed after six months. For example, the implant is composed of lactic acid polymer or copolymer (PLA, PGA . . . ).


Considering the specific mechanical characteristics of resorptive materials, and to solve the given problem of improving anchor and stability, the cylindrical cross-section is threaded and tapers in the direction of its free end.


To solve the given problem of enabling a deformation by elasticity, thus causing an expansion adapted to the geometry of the site and to the properties of the material, the flat cross-section zone has, substantially in its median portion, an opening adapted to enable elastic deformation of the zone. The opening defines at least two anchor arms.


It therefore appears that the combination of a cylindrical and threaded anchor zone and a flat-sectioned anchor zone is particularly advantageous considering the problem to be solved.


To solve the given problem of resisting the shear and flexion forces susceptible of occurring in the area of the bone site, between the two anchor zones, the body has a central zone of transition adapted to resist the shear and flexion forces occurring in the area of the bone site and adapted to serve as an abutment.


From this basic design of the implant, the anchor zones are either coaxial or angularly offset by between about 1° and 30° and, advantageously, by 10°. The bend between the anchor zones is located so as to substantially correspond to an arthrodesis line of the bones being considered.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention is explained in more detail hereinafter with reference to the attached drawings, in which:



FIG. 1 is a perspective view of the implant;



FIG. 2 is a front view of the implant before insertion into the bone part in question;



FIG. 3 is a side view corresponding to FIG. 2;



FIG. 4 is a view like FIG. 2 showing the position of the anchor arms of the flat section after insertion;



FIG. 5 is a perspective view of another advantageous embodiment of the implant;



FIGS. 6 and 7 show the installation of the implant into two bone parts.





DETAILED DESCRIPTION

The implant according to the invention has a one-piece body 1 of elongated shape and having a first proximal zone A1 and a second distal zone A2. The entire implant body is made of a resorptive material whose mechanical properties are determined for the implant to be resorbed in no less than about 6 months. In one embodiment, the implant is composed of lactic acid polymer or copolymer (PLA, PGA . . . ).


As will be described later in the description, the zones A1 and A2 have anchor formations for the respective bone parts. Taking into account the specific characteristics of the resorptive material and to attain the given object of anchor and stability, the zone A1 is of a cylindrical shape section whereas the other zone A2 is flat.


The zone A1 has a generally cylindrical outer surface 1a with a limited taper toward its free end. The surface 1a has a helical rib forming a screwthread 1a1.


The zone A2 is flat and has substantially in its center, an opening 1b adapted to enable elastic deformation of the zone A2. More particularly, the opening 1b defines at least two anchor arms 1c and 1d, each having at least one outwardly projecting tooth 1c1, 1d1.


Advantageously, between the two zones A1 and A2 the body 1 has a central zone C for transition adapted to resist shear and flexion forces that can occur at the end of a bone. By way of nonlimiting example, this median zone C can have a length of about 3.5 mm and a thickness of about 2 mm, for an overall implant length comprised between about 15 and 25 mm and a diameter of about 2 or 3 mm at the zone A1.


In the embodiment shown in FIG. 1, the two zones A1 and A2 are coaxial.


To solve the problem of adaptation to the shape of the implantation site, the anchor zones A1 and A2 can be offset at an angle α adapted to the geometry of the bone site. This angle α is comprised between about 1° and 30° and, advantageously, on the order of 10° when the implant is for foot arthrodesis (FIG. 5).


In this embodiment in which the two anchor zones are angularly offset, the bend is located so as to correspond substantially to the arthrodesis line of the bone parts being fused.



FIGS. 6 and 7 schematically show the positioning of the implant according to the invention between two bone parts O1 and O2. After suitable holes have been made in the bone by a rasp-type tool, the operator screws the thread 1a into the bone part O1 substantially up to step 2 of the median zone C providing a surface that, as shown, faces towards thread 1a in a direction parallel to a longitudinal axis defined by zones A1, A2 and serves as an abutment preventing the implant from sinking too deeply into the bone (see FIGS. 1, 5, 6, and 7). The operator then fits the second bone part O2 back onto the anchor arms 1d and 1c of the zone A2, the anchor arms then spread and tighten by elasticity (FIG. 7).


The operative technique can be the following:

    • Drilling of the two holes with a conventional drill;
    • Preparation of the holes with a rasp for the flat side and a bone tap to form the inner screw thread on the cylindrical side;
    • Use of a screwdriver with a gripper end;
    • Screwing in the cylindrical side P1 [A1] for an arthrodesis IPP of the foot;
    • Fitting of the bone back onto the flat side [A2] of the implant.


The advantages are readily apparent from the description; in particular, it is to be emphasized and understood that the combination of the two anchor zones A1 and A2 of cylindrical and a flat shape, respectively, significantly enhances anchor and stability of the implant adapted to the geometry of the bone site and to the material properties, namely, a resorptive material.

Claims
  • 1. An intramedullary implant for insertion into first and second bone parts, the implant being a one-piece body, the one-piece body comprising: a threaded first end for anchoring to the first bone part; anda second end extending from the first end for anchoring to the second bone part, the second end comprising: a body portion defining a longitudinal axis thereof;a first arm and a second arm projecting from the body portion;a first projection and a second projection spaced apart from the first projection, the first and the second projections extending from the first arm away from the longitudinal axis; anda third projection extending from the second arm in a different direction than the first projection,wherein the second end extends from the first end to form a step, the step having a surface facing in a direction parallel to the longitudinal axis and away from the second end.
  • 2. The intramedullary implant of claim 1, wherein the third projection extends in a different direction than the second projection extends from the first arm.
  • 3. The intramedullary implant of claim 1, wherein a fourth projection spaced apart from the third projection extends from the second arm.
  • 4. The intramedullary implant of claim 1, wherein the first and the second projections extend in a same direction.
  • 5. The intramedullary implant of claim 1, wherein the step defines a plane perpendicular to the longitudinal axis.
  • 6. The intramedullary implant of claim 1, wherein entireties of the first and the second arms are spaced from the longitudinal axis to define an opening therebetween.
  • 7. The intramedullary implant of claim 1, wherein the intramedullary implant is made of a polymer.
  • 8. The intramedullary implant of claim 1, wherein the first projection includes a first flat portion, the second projection includes a second flat portion, and the third projection includes a third flat portion, and wherein the first, the second, and the third flat portions are coplanar.
  • 9. The intramedullary implant of claim 1, wherein the first projection includes first and second opposing surface portions, the second projection includes third and fourth opposing surface portions, and the third projection includes fifth and sixth opposing surface portions, and wherein each of the first, the third, and the fifth opposing surface portions define a first plane and each of the second, the fourth, and the sixth opposing surface portions define a second plane parallel to the first plane.
  • 10. An intramedullary implant for insertion into first and second bone parts, the implant being a one-piece body, the one-piece body comprising: a threaded first end for anchoring to the first bone part; anda second end extending from the first end for anchoring to the second bone part, the second end comprising: a body portion defining an opening in a median portion thereof;a first plurality of projections extending from a first side of the body portion and extending away from the opening, each one of the first plurality of projections including a respective one of a first set of flat surface portions, the first set of flat surface portions being coplanar; anda second plurality of projections extending from a second side of the body portion opposite the first side and extending away from the opening, each one of the second plurality of projections including a respective one of a second set of flat surface portions, the second set of flat surface portions being coplanar.
  • 11. The intramedullary implant of claim 10, wherein the projections of the first plurality of projections extend away from the opening in a same direction.
  • 12. The intramedullary implant of claim 11, wherein the projections of the second plurality of projections extend away from the opening in a same direction.
  • 13. The intramedullary implant of claim 10, wherein the body portion includes a pair of arms and the opening is defined by the pair of arms.
  • 14. The intramedullary implant of claim 10, wherein the body portion defines a longitudinal axis, and wherein the second end extends from the first end to form a step defining a plane perpendicular to the longitudinal axis.
  • 15. The intramedullary implant of claim 10, wherein the intramedullary implant is made of a polymer.
  • 16. The intramedullary implant of claim 10, wherein the first and the second sets of flat surface portions are coplanar.
  • 17. The intramedullary implant of claim 10, wherein the first and the second sets of flat surface portions are coplanar.
  • 18. The intramedullary implant of claim 17, wherein the first plurality of projections include a third set of flat surface portions opposite respective ones of the first set of flat surface portions, the third set of flat surface portions being coplanar, and wherein the second plurality of projections include a fourth set of flat surface portions opposite respective ones of the second set of flat surface portions, the fourth set of flat surface portions being coplanar, and wherein each of the first, the second, the third, and the fourth sets of flat surface portions lie in parallel planes.
  • 19. An intramedullary implant for insertion into first and second bone parts, the implant being a one-piece body, the one-piece body comprising: a threaded first end for anchoring to the first bone part; anda second end extending from the first end for anchoring to the second bone part, the second end having a body portion, a first projection extending from a first side of the body portion, a second projection extending from a second side of the body portion opposite the first side, and a third projection extending from the first side of the body portion in a direction away from a longitudinal axis defined by the body portion, the first and the second projections extending in different directions away from the longitudinal axis and the third projection being spaced from the first projection,wherein the second end extends from the first end to form a step defining a plane perpendicular to the longitudinal axis, the step having a surface facing in a direction parallel to the longitudinal axis and away from the second end,wherein the first projection includes first and second opposing surface portions, the second projection includes third and fourth opposing surface portions, and the third projection includes fifth and sixth opposing surface portions, andwherein each of the first, the third, and the fifth opposing surface portions define a first plane and each of the second, the fourth, and the sixth opposing surface portions define a second plane parallel to the first plane.
  • 20. The intramedullary implant of claim 19, wherein the first and the second projections are in alignment relative to and spaced apart from the longitudinal axis.
  • 21. The intramedullary implant of claim 19, wherein the second end includes separated arms defining an opening, and wherein each of the first and the second projections extends from the separated arms.
Priority Claims (1)
Number Date Country Kind
0856035 Sep 2008 FR national
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/858,855, filed Sep. 18, 2015, which is a divisional of U.S. patent application Ser. No. 13/795,946, filed Mar. 12, 2013, now U.S. Pat. No. 9,168,074, which is a continuation of U.S. patent application Ser. No. 12/918,105, filed Oct. 29, 2010, now U.S. Pat. No. 8,414,583, which application is a U.S. national phase entry under 35 U.S.C. § 371 of International Application No. PCT/FR2009/051658, filed Sep. 2, 2009, published as WO 2010/029246, which claims priority from French Patent Application No. 0856035, filed Sep. 9, 2008, whose entire disclosures are herewith incorporated by reference.

US Referenced Citations (298)
Number Name Date Kind
321389 Schirmer Jun 1885 A
1095054 Wiesenfeld Apr 1914 A
2128005 Lombard Aug 1938 A
2208848 Jorgensen Jul 1940 A
2531911 Johnson Nov 1950 A
3338689 Hetzel et al. Aug 1967 A
3462765 Swanson Aug 1969 A
3466669 Flatt Sep 1969 A
3593342 Niebauer et al. Jul 1971 A
3646654 Cervenka et al. Mar 1972 A
3681786 Lynch Aug 1972 A
3739403 Nicolle Jun 1973 A
3805302 Mathys Apr 1974 A
3824631 Burstein et al. Jul 1974 A
3875594 Swanson Apr 1975 A
D243716 Treace et al. Mar 1977 S
4091806 Aginsky et al. May 1978 A
4158893 Swanson Jun 1979 A
4204284 Koeneman May 1980 A
4237875 Termanini Dec 1980 A
4276660 Laure Jul 1981 A
4364382 Mennen Dec 1982 A
4367562 Gauthier et al. Jan 1983 A
D277509 Lawrence et al. Feb 1985 S
D277784 Sgarlato et al. Feb 1985 S
4522200 Stednitz Jun 1985 A
D284099 Laporta et al. Jun 1986 S
4634382 Kusano et al. Jan 1987 A
D291731 Aikins Sep 1987 S
4759768 Hermann et al. Jul 1988 A
4871367 Christensen et al. Oct 1989 A
4955916 Carignan et al. Sep 1990 A
4969909 Barouk Nov 1990 A
5011497 Persson et al. Apr 1991 A
5047059 Saffar Sep 1991 A
5062851 Branemark Nov 1991 A
5092896 Meuli et al. Mar 1992 A
5108443 Branemark Apr 1992 A
5133761 Krouskop Jul 1992 A
5179915 Cohen et al. Jan 1993 A
5190546 Jervis Mar 1993 A
5207712 Cohen May 1993 A
5326364 Clift, Jr. et al. Jul 1994 A
5360450 Giannini Nov 1994 A
5382251 Hood et al. Jan 1995 A
5405400 Linscheid et al. Apr 1995 A
5405401 Lippincott, III et al. Apr 1995 A
5417692 Goble et al. May 1995 A
5425776 Cohen Jun 1995 A
5425777 Sarkisian et al. Jun 1995 A
5454814 Comte Oct 1995 A
5464427 Curtis et al. Nov 1995 A
5474557 Mai Dec 1995 A
5480447 Skiba Jan 1996 A
5484443 Pascarella et al. Jan 1996 A
5507822 Bouchon et al. Apr 1996 A
5522903 Sokolow et al. Jun 1996 A
5554157 Errico et al. Sep 1996 A
5634925 Urbanski Jun 1997 A
5674297 Lane et al. Oct 1997 A
5702472 Huebner Dec 1997 A
5725585 Zobel Mar 1998 A
5782927 Klawitter et al. Jul 1998 A
5824095 Di Maio, Jr et al. Oct 1998 A
5876434 Flomenblit et al. Mar 1999 A
5881443 Roberts et al. Mar 1999 A
5882444 Flomenblit et al. Mar 1999 A
5919193 Slavitt Jul 1999 A
5951288 Sawa Sep 1999 A
5958159 Prandi Sep 1999 A
5984970 Bramlet Nov 1999 A
5984971 Faccioli et al. Nov 1999 A
6011497 Tsang et al. Jan 2000 A
6017366 Berman Jan 2000 A
6146387 Trott et al. Nov 2000 A
6162234 Freedland et al. Dec 2000 A
6187008 Hamman Feb 2001 B1
6193757 Foley et al. Feb 2001 B1
6197037 Hair Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6248109 Stoffella Jun 2001 B1
6261289 Levy Jul 2001 B1
6319284 Rushdy et al. Nov 2001 B1
6342076 Lundborg Jan 2002 B1
6352560 Poeschmann et al. Mar 2002 B1
6383223 Baehler et al. May 2002 B1
6386877 Sutter May 2002 B1
6395031 Foley et al. May 2002 B1
6423097 Rauscher Jul 2002 B2
6428634 Besselink et al. Aug 2002 B1
6454808 Masada Sep 2002 B1
6475242 Bramlet Nov 2002 B1
6554833 Levy et al. Apr 2003 B2
6689169 Harris Feb 2004 B2
6692499 Tormala et al. Feb 2004 B2
6699247 Zucherman et al. Mar 2004 B2
6699292 Ogilvie et al. Mar 2004 B2
6706045 Lin Mar 2004 B2
6773437 Ogilvie et al. Aug 2004 B2
6811568 Minamikawa Nov 2004 B2
6827741 Reeder Dec 2004 B2
6833006 Foley et al. Dec 2004 B2
6869449 Ball et al. Mar 2005 B2
6896177 Carter May 2005 B2
6981974 Berger Jan 2006 B2
7025789 Chow et al. Apr 2006 B2
7037342 Nilsson et al. May 2006 B2
7041106 Carver May 2006 B1
7052498 Levy et al. May 2006 B2
7182787 Hassler et al. Feb 2007 B2
7240677 Fox Jul 2007 B2
7291175 Gordon Nov 2007 B1
7537664 O'Neill et al. May 2009 B2
7588603 Leonard Sep 2009 B2
7600956 McDuff et al. Oct 2009 B2
7601152 Levy et al. Oct 2009 B2
7655042 Foley et al. Feb 2010 B2
7670339 Levy et al. Mar 2010 B2
7674426 Grohowski, Jr. Mar 2010 B2
7780737 Bonnard et al. Aug 2010 B2
7837738 Reigstad et al. Nov 2010 B2
7842091 Johnstone et al. Nov 2010 B2
7909880 Grant Mar 2011 B1
7918879 Yeung et al. Apr 2011 B2
7922765 Reiley Apr 2011 B2
7955388 Jensen et al. Jun 2011 B2
7976580 Berger Jul 2011 B2
7993403 Foley et al. Aug 2011 B2
8048173 Ochoa Nov 2011 B2
8100983 Schulte Jan 2012 B2
8162942 Coati et al. Apr 2012 B2
8202305 Reiley Jun 2012 B2
8262712 Coilard-Lavirotte et al. Sep 2012 B2
8308779 Reiley Nov 2012 B2
8388667 Reiley et al. Mar 2013 B2
8394097 Peyrot et al. Mar 2013 B2
8414583 Prandi et al. Apr 2013 B2
8414648 Reiley Apr 2013 B2
8425570 Reiley Apr 2013 B2
8444693 Reiley May 2013 B2
8470004 Reiley Jun 2013 B2
8475456 Augoyard et al. Jul 2013 B2
8529611 Champagne et al. Sep 2013 B2
8597337 Champagne Dec 2013 B2
8608785 Reed et al. Dec 2013 B2
8685024 Roman Apr 2014 B2
8715325 Weiner et al. May 2014 B2
8728387 Jones et al. May 2014 B2
8734462 Reiley et al. May 2014 B2
8734491 Seavey May 2014 B2
8834483 Cheney et al. Sep 2014 B2
8834572 Averous et al. Sep 2014 B2
8840623 Reiley Sep 2014 B2
8840651 Reiley Sep 2014 B2
8858601 Reiley Oct 2014 B2
8864804 Champagne et al. Oct 2014 B2
8920477 Reiley Dec 2014 B2
8986348 Reiley Mar 2015 B2
8992703 O'Neill et al. Mar 2015 B2
8998999 Lewis et al. Apr 2015 B2
9011504 Reed Apr 2015 B2
9039743 Reiley May 2015 B2
9044287 Reed et al. Jun 2015 B2
9056014 McCormick et al. Jun 2015 B2
9072562 Weiner et al. Jul 2015 B2
9072564 Reed et al. Jul 2015 B2
9089427 Grohowski, Jr. Jul 2015 B2
9089431 Grohowski, Jr. Jul 2015 B2
D738504 Weiner et al. Sep 2015 S
9125704 Reed et al. Sep 2015 B2
9135374 Jones et al. Sep 2015 B2
9161789 Peyrot et al. Oct 2015 B2
9168074 Prandi et al. Oct 2015 B2
9180010 Dong et al. Nov 2015 B2
9283007 Augoyard et al. Mar 2016 B2
9403213 Lapszynski Aug 2016 B2
9452002 Roman et al. Sep 2016 B2
9492215 Augoyard et al. Nov 2016 B2
9498266 McCormick et al. Nov 2016 B2
9498273 Thoren et al. Nov 2016 B2
10022167 Augoyard et al. Jul 2018 B2
20010025199 Rauscher Sep 2001 A1
20010049529 Cachia et al. Dec 2001 A1
20020019636 Ogilvie et al. Feb 2002 A1
20020055785 Harris May 2002 A1
20020065561 Ogilvie et al. May 2002 A1
20020068939 Levy et al. Jun 2002 A1
20020082705 Bouman et al. Jun 2002 A1
20020169066 Cassidy et al. Nov 2002 A1
20030040805 Minamikawa Feb 2003 A1
20030069645 Ball et al. Apr 2003 A1
20030120277 Berger Jun 2003 A1
20030130660 Levy et al. Jul 2003 A1
20040002759 Ferree Jan 2004 A1
20040093081 Nilsson et al. May 2004 A1
20040102853 Boumann et al. May 2004 A1
20040138756 Reeder Jul 2004 A1
20040172031 Rubecamp Sep 2004 A1
20040220574 Pelo et al. Nov 2004 A1
20040220678 Chow et al. Nov 2004 A1
20050065589 Schneider et al. Mar 2005 A1
20050119757 Hassler et al. Jun 2005 A1
20050216015 Kreidler Sep 2005 A1
20050251265 Calandruccio et al. Nov 2005 A1
20050261768 Trieu Nov 2005 A1
20050283159 Amara Dec 2005 A1
20060036322 Reiley Feb 2006 A1
20060052725 Santilli Mar 2006 A1
20060052878 Schmieding Mar 2006 A1
20060074492 Frey Apr 2006 A1
20060084998 Levy et al. Apr 2006 A1
20060085075 McLeer Apr 2006 A1
20060147332 Jones et al. Jul 2006 A1
20060247787 Rydell et al. Nov 2006 A1
20070038303 Myerson et al. Feb 2007 A1
20070123993 Hassler et al. May 2007 A1
20070142920 Niemi Jun 2007 A1
20070156241 Reiley et al. Jul 2007 A1
20070162018 Jensen et al. Jul 2007 A1
20070185584 Kaufmann et al. Aug 2007 A1
20070213831 de Cubber Sep 2007 A1
20070239158 Trieu et al. Oct 2007 A1
20080039949 Meesenburg et al. Feb 2008 A1
20080132894 Coilard-Lavirotte Jun 2008 A1
20080154385 Trail et al. Jun 2008 A1
20080177262 Augoyard Jul 2008 A1
20080177291 Jensen Jul 2008 A1
20080195219 Wiley et al. Aug 2008 A1
20080221697 Graser Sep 2008 A1
20080221698 Berger Sep 2008 A1
20080234763 Patterson et al. Sep 2008 A1
20080269908 Warburton Oct 2008 A1
20090005821 Chirico et al. Jan 2009 A1
20090012564 Chirico et al. Jan 2009 A1
20090138096 Myerson et al. May 2009 A1
20090254189 Scheker Oct 2009 A1
20090254190 Gannoe et al. Oct 2009 A1
20100010637 Pequignot Jan 2010 A1
20100016905 Greenhalgh et al. Jan 2010 A1
20100016982 Solomons Jan 2010 A1
20100057214 Graham et al. Mar 2010 A1
20100121390 Kleinman May 2010 A1
20100131014 Peyrot May 2010 A1
20100131072 Schulte May 2010 A1
20100161068 Lindner et al. Jun 2010 A1
20100185295 Emmanuel Jul 2010 A1
20100228301 Greenhalgh et al. Sep 2010 A1
20100249942 Goswami et al. Sep 2010 A1
20100256731 Mangiardi Oct 2010 A1
20100256770 Hakansson et al. Oct 2010 A1
20100262254 Lawrence et al. Oct 2010 A1
20110004317 Hacking et al. Jan 2011 A1
20110093084 Morton Apr 2011 A1
20110093085 Morton Apr 2011 A1
20110144644 Prandi et al. Jun 2011 A1
20110208304 Justin et al. Aug 2011 A1
20110301652 Reed et al. Dec 2011 A1
20120029579 Bottlang et al. Feb 2012 A1
20120065692 Champagne et al. Mar 2012 A1
20120089197 Anderson Apr 2012 A1
20120259419 Brown et al. Oct 2012 A1
20130053975 Reed et al. Feb 2013 A1
20130060295 Reed et al. Mar 2013 A1
20130066435 Averous et al. Mar 2013 A1
20130123862 Anderson et al. May 2013 A1
20130131822 Lewis et al. May 2013 A1
20130150965 Taylor et al. Jun 2013 A1
20130190761 Prandi et al. Jul 2013 A1
20130190831 Ek et al. Jul 2013 A1
20130231744 Taylor et al. Sep 2013 A1
20130317559 Leavitt et al. Nov 2013 A1
20130325077 Champagne et al. Dec 2013 A1
20140005219 Foster et al. Jan 2014 A1
20140039630 Peyrot et al. Feb 2014 A1
20140058462 Reed et al. Feb 2014 A1
20140107712 Fallin et al. Apr 2014 A1
20140142715 McCormick May 2014 A1
20140180428 McCormick Jun 2014 A1
20140188239 Cummings Jul 2014 A1
20140257509 Dacosta et al. Sep 2014 A1
20140276827 Roman et al. Sep 2014 A1
20140277554 Roman et al. Sep 2014 A1
20140309747 Taylor et al. Oct 2014 A1
20140316474 Graham Oct 2014 A1
20140343615 Cheney et al. Nov 2014 A1
20150011998 McCormick Jan 2015 A1
20150066097 Biedermann Mar 2015 A1
20150073413 Palmer et al. Mar 2015 A1
20150094778 McCormick et al. Apr 2015 A1
20150112341 Penzimer et al. Apr 2015 A1
20150112342 Penzimer Apr 2015 A1
20150112446 Melamed et al. Apr 2015 A1
20150150607 Chen et al. Jun 2015 A1
20150164563 Lewis et al. Jun 2015 A1
20150223848 McCormick Aug 2015 A1
20150223850 Reed Aug 2015 A1
20150223853 Appenzeller et al. Aug 2015 A1
20150342655 Reed et al. Dec 2015 A1
Foreign Referenced Citations (75)
Number Date Country
2551021 Mar 2005 CA
2243699 Jan 2006 CA
2836654 Jun 2014 CA
2837497 Jun 2014 CA
0042808 Dec 1981 EP
0340159 Nov 1989 EP
0420794 Apr 1991 EP
0454645 Oct 1991 EP
1300122 Apr 2003 EP
1356794 Nov 2003 EP
1582159 Oct 2005 EP
1923012 May 2008 EP
2228015 Mar 2011 EP
2471477 Jul 2012 EP
2471478 Jul 2012 EP
2544633 Jan 2013 EP
2749236 Oct 2014 EP
2663838 Jan 1992 FR
2725126 Apr 1996 FR
2783702 Mar 2000 FR
2787313 Jun 2000 FR
2794019 Dec 2000 FR
2801189 May 2001 FR
2846545 May 2004 FR
2856269 Dec 2004 FR
2884406 Oct 2006 FR
2927529 Aug 2009 FR
2935601 Mar 2010 FR
2957244 Sep 2011 FR
2119655 Nov 1983 GB
2430625 Apr 2007 GB
S60145133 Jul 1985 JP
03001854 Aug 1991 JP
H7303662 Nov 1995 JP
2004535249 Nov 2004 JP
3648687 May 2005 JP
2007530194 Nov 2007 JP
2008188411 Aug 2008 JP
2008537696 Sep 2008 JP
4695511 Jun 2011 JP
5631597 Nov 2014 JP
5645826 Dec 2014 JP
20070004513 Jan 2007 KR
20070022256 Feb 2007 KR
101004561 Jan 2011 KR
101235983 Feb 2013 KR
9116014 Oct 1991 WO
9625129 Aug 1996 WO
9641596 Dec 1996 WO
9726846 Jul 1997 WO
9733537 Sep 1997 WO
0117445 Mar 2001 WO
03084416 Oct 2003 WO
2005020831 Mar 2005 WO
2005020830 Mar 2005 WO
2005063149 Jul 2005 WO
2005104961 Nov 2005 WO
2006109004 Oct 2006 WO
2007135322 Nov 2007 WO
2008057404 May 2008 WO
2008112308 Sep 2008 WO
2008129214 Oct 2008 WO
2009055952 May 2009 WO
2009103085 Aug 2009 WO
2010029246 Mar 2010 WO
2011082343 Jul 2011 WO
2011110784 Sep 2011 WO
2011116078 Sep 2011 WO
2011130229 Oct 2011 WO
2012089330 Jul 2012 WO
2012089331 Jul 2012 WO
2013164819 Nov 2013 WO
2014031947 Feb 2014 WO
2014165123 Oct 2014 WO
2015136212 Sep 2015 WO
Non-Patent Literature Citations (15)
Entry
EP Notification for Application No. 09741356.1 dated Feb. 12, 2015, 4 pages.
HammerFix IP Fusion System, Hammertoe Deformity Surgical Technique, designed by Extremity Medical, published Mar. 31, 2014 (8 pages).
International Search Report for PCT/FR2008/050453 dated Nov. 4, 2008, 4 pages.
International Search Report, PCT/FR2006/050345, dated Aug. 30, 2006, 3 pages.
Intraosseous Fixation System, Hammertoe Surgical Technique, designed by OrthoHelix, published Aug. 23, 2012 (16 pages).
Japanese Office Action for Application No. 2011-526540 dated Aug. 13, 2013, 3 pages.
Pietrzak WS, et al., “A bioabsorbable fixation implant for use in proximal interphalangeal joint (hammer toe) arthrodesis: Biomechanical testing in a synthetic bone substrate”. J Foot Ankle Surg. Sep.-Oct. 2006;45(5):288-94. doi: 10.1053/j.jfas.2006.05.004. PMID: 16949524. 7 pgs. [Exhibit No. 1007 to Petition for Inter Partes Review of U.S. Pat. No. 9,168,074].
The American Heritage College Dictionary, Fourth Edition, Houghton Mifflin Company (Apr. 2007). 3 pgs. [Exhibit No. 1008 to Petition for Inter Partes Review of U.S. Pat. No. 9,168,074].
Cross section, https://byjus.com/maths/cross-section/ (last visited Jan. 26, 2022). 4 pgs. [Exhibit No. 1009 to Petition for Inter Partes Review of U.S. Pat. No. 9,168,074].
Declaration of Michael Sherman (Jan. 28, 2022). 119 pgs. [Exhibit No. 1002 to Petition for Inter Partes Review of U.S. Pat. No. 9,168,074].
Petition for Inter Partes Review of U.S. Pat. No. 9,168,074 , OsteoMed LLC v. Stryker European Operations Holdings LLC. (Jan. 28, 2022). 98 pgs.
Patent Owner's Preliminary Response and Exhibits List, IPR2022-00486 of U.S. Pat. No. 9,168,074 , OsteoMed LC v. Stryker European Operations Holdings LLC. (Filed May 16, 2022), 77 pages. [Including Appendices at Exhibits 2003 and 2004].
Collins English Dictionary Excerpt (Jun. 2007), 6 pages. [Exhibit No. 2001 to Patent Owner's Preliminary Response, IPR2022-00486 of U.S. Pat. No. 9,168,074 filed May 16, 2022].
Excerpt from Tool.com—File and Rasp Tools, (Copyright 2022), 6 pages. [Exhibit No. 2002 to Patent Owner's Preliminary Response, IPR2022-00486 of U.S. Pat. No. 9,168,074 filed May 16, 2022].
Jung, H. J. et al., JJ., Decision Denying Institution of Inter Partes Review, IPR2022-00486 of U.S. Pat. No. 9,168,074 , OsteoMed LLC v. Stryker European Operations Holdings LLC. (Aug. 12, 2022). 42 pages.
Related Publications (1)
Number Date Country
20190328433 A1 Oct 2019 US
Divisions (1)
Number Date Country
Parent 13795946 Mar 2013 US
Child 14858855 US
Continuations (2)
Number Date Country
Parent 14858855 Sep 2015 US
Child 16506353 US
Parent 12918105 US
Child 13795946 US